Related Experiment Video
Updated: Aug 27, 2025

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR
Sabine Bauer1,2, Jana Eigenmann1, Yuqi Zhao3
1Department of Cardiology, German Heart Centre Munich, Technical University Munich, 80636 Munich, Germany.
Abstract:
Coronary artery disease (CAD) is a complex, multifactorial disease caused, in particular, by inflammation and cholesterol metabolism. At the molecular level, the role of tissue-specific signaling pathways leading to CAD is still largely unexplored. This study relied on two main resources: (1) genes with impact on atherosclerosis/CAD, and (2) liver-specific transcriptome analyses from human and mouse studies. The transcription factor activating transcription factor 3 (ATF3) was identified as a key regulator of a liver network relevant to atherosclerosis and linked to inflammation and cholesterol metabolism. ATF3 was predicted to be a direct and indirect (via MAF BZIP Transcription Factor F (MAFF)) regulator of low-density lipoprotein receptor (LDLR). Chromatin immunoprecipitation DNA sequencing (ChIP-seq) data from human liver cells revealed an ATF3 binding motif in the promoter regions of MAFF and LDLR. siRNA knockdown of ATF3 in human Hep3B liver cells significantly upregulated LDLR expression (p < 0.01). Inflammation induced by lipopolysaccharide (LPS) stimulation resulted in significant upregulation of ATF3 (p < 0.01) and subsequent downregulation of LDLR (p < 0.001). Liver-specific expression data from human CAD patients undergoing coronary artery bypass grafting (CABG) surgery (STARNET) and mouse models (HMDP) confirmed the regulatory role of ATF3 in the homeostasis of cholesterol metabolism. This study suggests that ATF3 might be a promising treatment candidate for lowering LDL cholesterol and reducing cardiovascular risk.
Insights
Activating transcription factor 3 (ATF3) regulates liver networks impacting cholesterol and inflammation in coronary artery disease (CAD). Targeting ATF3 may offer a novel approach to reduce cardiovascular risk by managing LDL cholesterol.
Area of Science:
- Molecular biology
- Cardiovascular research
- Genetics
Background:
- Coronary artery disease (CAD) involves complex inflammation and cholesterol metabolism.
- Tissue-specific signaling pathways in CAD pathogenesis remain under-explored.
Purpose of the Study:
- Identify key molecular regulators in liver networks relevant to atherosclerosis.
- Investigate the role of activating transcription factor 3 (ATF3) in cholesterol metabolism and inflammation.
Main Methods:
- Analysis of liver-specific transcriptomes from human and mouse studies.
- Chromatin immunoprecipitation DNA sequencing (ChIP-seq) in human liver cells.
- siRNA knockdown experiments in Hep3B liver cells.
- Examination of human (STARNET) and mouse (HMDP) liver expression data.
Main Results:
- ATF3 identified as a key regulator of liver networks linked to atherosclerosis, inflammation, and cholesterol.
- ATF3 directly and indirectly regulates low-density lipoprotein receptor (LDLR) expression.
- ATF3 binding motifs found in MAFF and LDLR promoter regions.
- ATF3 knockdown upregulates LDLR; LPS-induced inflammation upregulates ATF3 and downregulates LDLR.
Conclusions:
- ATF3 plays a significant role in regulating cholesterol metabolism and inflammation in the liver.
- ATF3 is a potential therapeutic target for managing LDL cholesterol levels.
- Targeting ATF3 may reduce cardiovascular risk in patients with coronary artery disease.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Master Transcription Regulators
General Transcription Factors
Co-activators and Co-repressors
Transcription Factors
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Nuclear Protein Sorting